Breast Cancer Clinical Trial

The MEDITATE-BC Study: Mindfulness-Enhanced Decision Intervention To Aid Treatment Election – Breast Cancer

Summary

In this study the investigators propose to pilot test a brief, mindfulness shared decision making intervention that begins shortly after receiving a diagnosis of breast cancer. A mindfulness instructor will conduct an hour long session with consented participants before the scheduled surgical appointment. The investigators hypothesize that a mindfulness intervention delivered shortly after receiving a diagnosis of breast cancer may ultimately lead to increased decisional satisfaction and alignment to participant's values and preferences, and decreased anxiety. To measure this endpoint, participants will complete three surveys via REDCap- at baseline, before surgery, and 6 months postoperatively. Surveys will include questions on quality of life, anxiety, and participant satisfaction with the mindfulness program.

View Full Description

Full Description

The primary aim of this study is to identify if a mindfulness intervention is feasible before the participant has their surgical consultation. The secondary aim is to measure the impact of the mindfulness intervention on participant reported outcomes including anxiety, quality of life and decisional satisfaction. Newly diagnosed female breast cancer patients will be contacted over the phone after the patient learns of their diagnosis but prior to their surgical appointment to discuss surgical options. Verbal consent will be obtained over the phone and the participant will be directed to complete an online survey to answer baseline questions on their anxiety and quality of life as well as to provide their contact information and availability in order to schedule a mindfulness session with a certified mindfulness teacher. The participant will then proceed to an hour-long mindfulness exercise geared to help women apply these techniques to the decisional making process. The goal is to empower women to approach their diagnosis and treatment decisions with greater stability and improve their ability to focus on their values and preferences instead of just focusing on the diagnosis. This will be measured by administering patient reported outcomes (PROs) via REDCap online surveys at three timepoints. The first PRO "baseline survey" is administered after the participant enrolls but before the mindfulness session. The second PRO "before surgery survey" is completed after the surgical consultation but prior to the scheduled surgery. The final PRO "6-month survey" is administered 6 months after the surgery to measure quality of life, anxiety, and participant satisfaction with the mindfulness program. The investigators hypothesize that a mindfulness intervention delivered shortly after receiving a diagnosis of breast cancer may ultimately lead to increased decisional satisfaction and alignment to participant's values and preferences, and decreased anxiety.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Females >20 and < 70 years of age
History of contralateral breast cancer in the past is acceptable
Patients seeking second opinion for diagnosis are eligible
Clinical AJCC stage 0-III breast cancer
Patients who have an in breast tumor recurrence are eligible
English Speaking
Willing to fill out surveys required for the study
Gene mutation carriers are eligible
Neoadjuvant therapy patients are eligible

Exclusion Criteria:

AJCC Stage IV breast cancer
Unwilling to fill out surveys for the study
Patients with a distant recurrence
Patients unaware of their diagnosis

Study is for people with:

Breast Cancer

Estimated Enrollment:

22

Study ID:

NCT03880799

Recruitment Status:

Completed

Sponsor:

NorthShore University HealthSystem

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

NorthShore University HealthSystem
Evanston Illinois, 60201, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

22

Study ID:

NCT03880799

Recruitment Status:

Completed

Sponsor:


NorthShore University HealthSystem

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider